Giulia Di Lullo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.
Journal: Cancer immunology, immunotherapy : CII
Published: October 30, 2019
Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris.
Journal: Frontiers in immunology
Published: March 15, 2019
Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma.
Journal: Frontiers in immunology
Published: September 21, 2018
Quantitative and Qualitative Analysis of Tumor-Associated CD4⁺ T Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 02, 2016
Non-redundant roles for Th17 and Th22 cells in multiple myeloma clinical correlates.
Journal: Oncoimmunology
Published: July 31, 2015
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.
Journal: Oncoimmunology
Published: December 01, 2014
Estimating point and interval frequency of antigen-specific CD4+ T cells based on short in vitro expansion and improved poisson distribution analysis.
Journal: PloS one
Published: May 02, 2012
Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.
Journal: The Journal of clinical investigation
Published: April 19, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026